S&P 500   3,390.51 (+0.60%)
DOW   29,375.27 (+0.49%)
QQQ   237.12 (+1.02%)
FB   217.17 (-0.29%)
MSFT   187.37 (+0.07%)
GOOGL   1,528.41 (+0.59%)
AMZN   2,182.53 (+1.25%)
CGC   21.73 (-0.96%)
NVDA   310.58 (+4.72%)
BABA   221.79 (+0.58%)
MU   58.93 (+2.04%)
GE   12.91 (+1.25%)
TSLA   941.49 (+9.68%)
AMD   58.69 (+3.16%)
ACB   1.70 (+3.66%)
F   8.05 (-0.25%)
NFLX   388.68 (+0.23%)
BAC   34.72 (+1.31%)
DIS   140.62 (+1.06%)
GILD   66.93 (-0.13%)
S&P 500   3,390.51 (+0.60%)
DOW   29,375.27 (+0.49%)
QQQ   237.12 (+1.02%)
FB   217.17 (-0.29%)
MSFT   187.37 (+0.07%)
GOOGL   1,528.41 (+0.59%)
AMZN   2,182.53 (+1.25%)
CGC   21.73 (-0.96%)
NVDA   310.58 (+4.72%)
BABA   221.79 (+0.58%)
MU   58.93 (+2.04%)
GE   12.91 (+1.25%)
TSLA   941.49 (+9.68%)
AMD   58.69 (+3.16%)
ACB   1.70 (+3.66%)
F   8.05 (-0.25%)
NFLX   388.68 (+0.23%)
BAC   34.72 (+1.31%)
DIS   140.62 (+1.06%)
GILD   66.93 (-0.13%)
S&P 500   3,390.51 (+0.60%)
DOW   29,375.27 (+0.49%)
QQQ   237.12 (+1.02%)
FB   217.17 (-0.29%)
MSFT   187.37 (+0.07%)
GOOGL   1,528.41 (+0.59%)
AMZN   2,182.53 (+1.25%)
CGC   21.73 (-0.96%)
NVDA   310.58 (+4.72%)
BABA   221.79 (+0.58%)
MU   58.93 (+2.04%)
GE   12.91 (+1.25%)
TSLA   941.49 (+9.68%)
AMD   58.69 (+3.16%)
ACB   1.70 (+3.66%)
F   8.05 (-0.25%)
NFLX   388.68 (+0.23%)
BAC   34.72 (+1.31%)
DIS   140.62 (+1.06%)
GILD   66.93 (-0.13%)
S&P 500   3,390.51 (+0.60%)
DOW   29,375.27 (+0.49%)
QQQ   237.12 (+1.02%)
FB   217.17 (-0.29%)
MSFT   187.37 (+0.07%)
GOOGL   1,528.41 (+0.59%)
AMZN   2,182.53 (+1.25%)
CGC   21.73 (-0.96%)
NVDA   310.58 (+4.72%)
BABA   221.79 (+0.58%)
MU   58.93 (+2.04%)
GE   12.91 (+1.25%)
TSLA   941.49 (+9.68%)
AMD   58.69 (+3.16%)
ACB   1.70 (+3.66%)
F   8.05 (-0.25%)
NFLX   388.68 (+0.23%)
BAC   34.72 (+1.31%)
DIS   140.62 (+1.06%)
GILD   66.93 (-0.13%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Seattle GeneticsNOVOZYMES A/S/SNeurocrine BiosciencesBioNTechBIO-TECHNE
SymbolNASDAQ:SGENOTCMKTS:NVZMYNASDAQ:NBIXNASDAQ:BNTXNASDAQ:TECH
Price Information
Current Price$120.01$55.28$104.15$30.95$208.03
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$122.12N/A$117.00$26.13$238.33
% Upside from Price Target1.76% upsideN/A12.34% upside-15.59% downside14.57% upside
Trade Information
Market Cap$20.34 billion$16.24 billion$9.67 billion$6.96 billion$8.00 billion
Beta20.811.53N/A1.25
Average Volume951,05813,136660,365189,339171,198
Sales & Book Value
Annual Revenue$916.71 million$2.28 billion$788.10 million$150.67 million$714.01 million
Price / Sales22.557.2012.2046.4811.17
CashflowN/A$1.74 per share$0.68 per shareN/A$5.95 per share
Price / CashN/A31.77152.96N/A34.94
Book Value$10.89 per share$6.10 per share$6.90 per shareN/A$34.51 per share
Price / Book11.029.0615.096.03
Profitability
Net Income$-158,650,000.00$511 million$37.01 million$-56,710,000.00$96.07 million
EPS($1.33)$1.75$0.39N/A$3.80
Trailing P/E RatioN/A34.33315.610.0041.94
Forward P/E RatioN/A33.7019.50N/A40.24
P/E GrowthN/A$2.67$1.23N/A$4.55
Net Margins-17.31%21.08%4.70%N/A26.20%
Return on Equity (ROE)-13.99%26.90%8.27%N/A12.45%
Return on Assets (ROA)-11.70%14.94%3.86%N/A7.80%
Dividend
Annual PayoutN/A$0.50N/AN/A$1.28
Dividend YieldN/A0.90%N/AN/A0.62%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A28.57%N/AN/A33.68%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.23%0.14%N/A0.33%
Current Ratio4.54%1.29%1.47%3.91%4.43%
Quick Ratio4.21%0.76%1.44%3.83%3.52%
Ownership Information
Institutional Ownership Percentage91.87%0.11%95.30%1.20%92.73%
Insider Ownership Percentage33.80%N/A4.30%N/A4.20%
Miscellaneous
Employees1,6056,4275851,1792,250
Shares Outstanding172.26 million297.00 million92.29 million226.26 million38.35 million
Next Earnings Date4/23/2020 (Estimated)2/20/2020 (Estimated)5/4/2020 (Estimated)N/A5/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel